Avelumab in Previously Untreated Patients with Epithelial Ovarian Cancer (Javelin Ovarian 100)

A Randomized, Open-Label, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Avelumab (MSB0010718C) in Combination With and/or Following Chemotherapy in Patients With Previously Untreated Epithelial Ovarian Cancer

Category & Conditions:
Cancer
Medicine:
BAVENCIO(AVELUMAB)
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
B9991010
Open Plain Language Summary Result:Click here